The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: A confocal laser-scanning microscopy study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 4, 2009, Pages 523-534

  Falke, Karen ^a   Büttner, Armin ^a   Schittkowski, Michael ^a   Stachs, Oliver ^a   Kraak, Robert ^a   Zhivov, Andrey ^a   Rolfs, Arndt ^a   Guthoff, Rudolf ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Amiodarone; Confocal microscopy; Cornea verticillata; Fabry disease

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; AMIODARONE; AMPHOPHILE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA VERTICILLATA; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE RECONSTRUCTION; IN VIVO STUDY; KERATOPATHY; MALE; MICROSCOPIC ANATOMY; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; SLIT LAMP; THREE DIMENSIONAL IMAGING; TISSUE STRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CONJUNCTIVA; CORNEA; CORNEAL DISEASES; FABRY DISEASE; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 62149126304     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0962-9     Document Type: Article

References (42)

1. Fleischer B (1910) Über eine eigenartige bisher nicht bekannte Hornhauttrübung. Albrecht Graefes Arch Ophthalmologie 77:136-140 doi: 10.1007/BF02229811
2. François J (1969) Cornea verticillata. Doc Ophthalmol 27:235-251 Den Haag doi: 10.1007/BF00208693
3. François J, Hanssens M, Teuchy H (1978) Corneal ultrastructural changes in Fabry's disease. Ophthalmologica 176:313-330
4. Denden A (1966) Über die Erblichkeit der Dystrophia cornea verticillata. Albrecht Von Graefes Arch Klin Exp Ophthalmol 169:264-271 doi: 10.1007/BF00429345
5. Grau AJ, Schwaninger M, Goebel HH, Beck M (2003) Morbus Fabry: Eine lysosomale Stoffwechselerkrankung mit neuen therapeutischen Möglichkeiten. Nervenarzt 74:489-496 doi: 10.1007/s00115-003-1577-3
6. Witschel H, Meyer W (1968) Der Morbus Fabry als Beispiel einer erblichen Lipoidspeicherkrankheit: Neuere Gesichtspunkte zur Pathogenese, Klinik und Morphologie. Klin Wochenschr 46:72-76 doi: 10.1007/BF01747471
7. Mehta A, Ricci R, Widmer U et al (2004) Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236-242 doi: 10.1111/j.1365-2362.2004.01309.x
8. Ries M, Ramaswami U, Parini R et al (2003) The early clinical phenotype of Fabry disease: A study on 35 European children and adolescents. Eur J Pediatr 162:767-772 doi: 10.1007/s00431-003-1299-3
9. Orssaud C, Dufier JL, Germain DP (2003) Ocular manifestations in Fabry disease: A survey of 32 hemizygous male patients. Ophthalmic Genet 24:129-139 doi: 10.1076/opge.24.3.129.15609
10. Sher NA, Letson RD, Desnick RJ (1979) The ocular manifestations in Fabry's disease. Arch Ophthalmol 97:671-676
11. Andersen M, Dahl H, Fledelius H, Nielsen N (1994) Central artery occlusion in a patient with Fabry's disease documented by scanning laser ophthalmoscopy. Acta Ophthalmol (Copenh) 72:635-638
12. Nguyen TT, Gin T, Nicholls K et al (2005) Ophthalmological manifestations of Fabry disease: A survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Experiment Ophthalmol 33:164-168 doi: 10.1111/j.1442-9071.2005.00990.x
13. Ohkubo H (1988) Several functional and fluorescein fundus angiographic findings in Fabry's disease. Ophthalmologica 196:132-136
14. Sodi A, Ioannidis AS, Mehta A et al (2007) Ocular manifestations of Fabry's disease: Data from the Fabry Outcome Survey. Br J Ophthalmol 91:210-214 doi: 10.1136/bjo.2006.100602
15. Eng CM, Banikazemi M, Gordon RE 3rd et al (2001) A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 68:711-722 doi: 10.1086/ 318809
16. Schiffmann R, Kopp JB, Austin HA 3rd et al (2001) Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA 285:2743-2749 doi: 10.1001/jama.285.21.2743
17. Roussel T, Grutzmacher R, Coster D (1984) Patterns of superficial keratopathy. Aust J Ophthalmol 12:301-316 doi: 10.1111/ j.1442-9071.1984.tb01174.x
18. Seiler KU, Thiel HJ, Wassermann O (1977) Die Chloroquinkeratopathie als Beispiel einer arzneimittelinduzierten Phospholipidosis (zugleich ein Beitrag zur Pathogenese der Cornea verticillata). Klin Monatsbl Augenheilkd 170:64-73
19. Bangham AD, Dawson RMC (1959) The relation between the activity of a lecithinase and the electrophoretic charge of the substrate. Biochem J 72:486-492
20. Stave J, Zinser G, Grümmer G, Guthoff RF (2002) Der modifizierte Heidelberg-Retina-Tomograph HRT. Erste Ergebnisse einer In-vivo-Darstellung von kornealen Strukturen. Ophthalmologe 99:276-280 doi: 10.1007/s003470100535
21. Eckard A, Stave J, Guthoff RF (2006) In vivo investigations of the corneal epithelium with the confocal Rostock Laser Scanning Microscope (RLSM). Cornea 25:127-131 doi: 10.1097/01.ico.0000170694.90455.f7
22. Guthoff RF, Stave J (2006) In vivo micromorphology of the cornea: confocal microscopy principles and clinical applications. In: Reinhard T, Larkin F (eds) Essentials in ophthalmology: Cornea and external eye disease. Springer, Berlin Heidelberg New York, pp 173-208
23. Guthoff RF, Wienss H, Hahnel C, Wree A (2005) Epithelial innervation of human cornea: A three-dimensional study using confocal laser scanning fluorescence microscopy. Cornea 24:608-613 doi: 10.1097/ 01.ico.0000154384.05614.8f
24. Hahnel C, Somodi S, Weiss DG, Guthoff RF (2000) The keratocyte network of human cornea: A three-dimensional study using confocal laser scanning fluorescence microscopy. Cornea 19:185-193 doi: 10.1097/ 00003226-200003000-00012
25. Orlando RG, Dangel ME, Schaal SF (1984) Clinical experience and grading of amiodarone keratopathy. Ophthalmology 91:1184-1187
26. Dolan BJ, Flach AJ, Peterson JS (1985) Amiodarone keratopathy and lens opacities. J Am Optom Assoc 56:468-470
27. Ciancaglini M, Carpineto P, Zuppardi E et al (2001) In vivo confocal microscopy of patients with amiodarone-induced keratopathy. Cornea 20:368-373 doi: 10.1097/00003226-200105000-00007
28. Rath R, Stave J, Guthoff RF et al (2006) In-vivo-Darstellung des Bindehautepithels: Eine vergleichende morphologische Untersuchung mittels konfokaler Laser-Scanning-Mikroskopie und Impressionszytologie. Ophthalmologe 103:401-405 doi: 10.1007/s00347-006-1337-4
29. Fumex-Boizard L, Cochat P, Fouilhoux A et al (2005) Relation entre les manifestations ophtalmologiques et les atteintes générales chez dix patients atteints de la maladie de Fabry. J Fr Ophtalmol 28:45-50 doi: 10.1016/S0181-5512(05)81024-1
30. Mastropasqua L, Nubile M, Lanzini M et al (2006) Corneal and conjunctival manifestations in Fabry disease: In vivo confocal microscopy study. Am J Ophthalmol 141:709-718 doi: 10.1016/ j.ajo.2005.11.053
31. Tsutsumi A, Uchida Y, Kanai T (1984) Corneal findings in a foetus with Fabry's disease. Acta Ophthalmol (Copenh) 62:923-931
32. Hirano K, Murata K, Miyagawa A et al (2001) Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease. Cornea 20:233-236 doi: 10.1097/00003226-200103000-00028
33. Slowik C, Somodi S, von Gruben C et al (1997) Erfassung morphologischer Hornhautveränderungen infolge Chloroquintherapie mit Hilfe der konfokalen In-vivo-Mikroskopie. Ophthalmologe 94:147-151 doi: 10.1007/ s003470050096
34. Libert J, Tondeur M, Van Hoof F (1976) The use of conjunctival biopsy and enzyme analysis in tears for the diagnosis of homozygotes and heterozygotes with Fabry disease. Birth Defects Orig Artic Ser 12:221-239
35. Guthoff RF, Baudouin C, Stave J (2006) Atlas of confocal laser scanning in-vivo microscopy in ophthalmology. Springer, Berlin Heidelberg New York
36. Bastion ML, Mohamad MH (2006) Study of the factors associated with the presence of white dots in the corneas of regular soft contact lens users from an Asian country. Eye Contact Lens 32:223-227 doi: 10.1097/ 01.icl.0000199891.35160.68
37. Macrae WG, Ghosh M, McCulloch C (1985) Corneal changes in Fabry's disease: A clinico-pathologic case report of a heterozygote. Ophthalmic Paediatr Genet 5:185-190 doi: 10.3109/13816818509006132
38. McCulloch C, Ghosh M (1984) Ultrastructural changes in the cornea and conjunctiva of a heterozygous woman with Fabry's disease. Can J Ophthalmol 19:192-198
39. Knop E, Knop N (2005) The role of eye-associated lymphoid tissue in corneal immune protection. J Anat 206:271-285 doi: 10.1111/ j.1469-7580.2005.00394.x
40. Knop N, Knop E (2000) Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 41:1270-1279
41. D'Amico DJ, Kenyon KR (1981) Drug-induced lipidoses of the cornea and conjunctiva. Int Ophthalmol 4:67-76 doi: 10.1007/BF00139581
42. Morris S, Tranos P, Evans S et al (2003) Ocular manifestations of Fabry disease: Effect of enzyme replacement therapy. Acta Paediatr 92(Suppl 443):110-115 doi: 10.1080/08035320310000492